Correction
After the publication of this work [1], we became aware of the fact that there was date mistakes in the Abstract, Patients and method and Results sections. The correct text is included below.
In the 'Methods' section of the Abstract, the first sentence should have read:
"The clinical and follow-up data of 124 patients who were referred to our department for SIRT between June 2008 and October 2010 were evaluated retrospectively."
In The 'Patients' section of the Patients and Method, the first sentence should have read:
"The clinical and follow-up data of 124 patients who were referred to our department for SIRT between June 2008 and October 2010 were evaluated retrospectively."
In the 'Patients' section of the Results, the first sentence should have read:
"78 patients (49 M; 29 F; mean age: 62.4+2.3 years) received intra-arterial radionuclide treatments with 90 Y for liver metastasis or primary HCC between June 2008 and October 2010."
Contributor Information
N Ozlem Kucuk, Email: csoydal@yahoo.com.
Cigdem Soydal, Email: csoydal@yahoo.com.
Seda Lacin, Email: csoydal@yahoo.com.
Elgin Ozkan, Email: csoydal@yahoo.com.
Sadık Bilgic, Email: csoydal@yahoo.com.
References
- Ozlem Kucuk N, SOYDAL Cigdem, Lacin Seda. et al. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors. World J Surg Oncol. 2011;9:86. doi: 10.1186/1477-7819-9-86. [DOI] [PMC free article] [PubMed] [Google Scholar]